BIT
TRIV

BlackRock Institutional Trust’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

BlackRock Institutional Trust’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,700
Closed -$71K – 4018
2015
Q4 		$71K Hold
10,700
– – ﹤0.01% 3786
2015
Q3 		$54K Hold
10,700
– – ﹤0.01% 3804
2015
Q2 		$57K Sell
10,700
-48,924
-82% -$347K ﹤0.01% 3774
2015
Q1 		$625K Sell
59,624
-680
-1% -$7.01K ﹤0.01% 3463
2014
Q4 		$758K Sell
60,304
-3,761
-6% -$51.3K ﹤0.01% 3414
2014
Q3 		$928K Buy
+64,065
New +$930K ﹤0.01% 3343

BlackRock Institutional Trust's TRIV Position: Q1 2016 in Review

BlackRock Institutional Trust sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 10,700 shares — an estimated $71K sold.

BlackRock Institutional Trust first reported a position in TRIV in Q3 2014 and held it in 6 quarters. The position peaked at $928K in Q3 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

  • BlackRock Institutional Trust reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 10,700 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $71K.
  • BlackRock Institutional Trust first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q3 2014 and held it in 6 quarters.
  • BlackRock Institutional Trust's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $928K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on BlackRock Institutional Trust's 13F filing for Q1 2016, filed 10 May 2016.